When evaluating new biomarkers for colon cancer, MUC1, MUC2, MUC4, MUC5AC, and MUC6 are currently documented in the largest bodies of work regarding their role in the progression from normal colonic tissue to malignancy. This evidence concerns the gene MUC6 and malignant colon neoplasm.